{"nct_id":"NCT02342704","title":"Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants","status":"TERMINATED","status_verified_date":"2017-05","start_date":"2014-11-30","start_date_type":"ACTUAL","primary_completion_date":"2016-05-18","primary_completion_date_type":"ACTUAL","completion_date":"2016-05-18","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["BIIB"]}